Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
Hematologic Oncology Update
00:00
Challenges of Generating Order Sets and Management of Conditional Toxicity in a New Therapy
The chapter discusses the difficulties in predicting and managing conditional toxicity when generating order sets for a new therapy. Community oncologists are encouraged to gain access and include the therapy in their pathways.
Transcript
Play full episode
